Total compensation includes information disclosed in company proxy statements, including base salary, bonus, stock awards and option awards, as well as other benefits and perks.
1. Albert Bourla, PhD, Pfizer (New York City) — $30.54 million
2. Christopher Viehbacher, Biogen (Cambridge, Mass.) — $30.49 million
3. Ari Bousbib, IQVIA Holdings (Durham, N.C.) — $29.71 million
4. Marc Casper, Thermo Fisher Scientific (Waltham, Mass.) — $28.21 million
5. Franis deSouza, Illumina (San Diego) — $26.75 million *Mr. deSouza left the CEO position June 11.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.